Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Johnson & Johnson (JNJ) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Johnson & Johnson (JNJ), most recent 12 months reported: revenue $99.33B, net income $16.09B, free cash flow $20.59B. Latest balance sheet on file: liquid cash $20.1B, total debt $47.93B, net cash -$27.83B. From SEC filings. More on Johnson & Johnson: Revenue · Profitability · Cash flow · Debt · Dividends Others in Pharmaceutical Preparations: ELI LILLY AND COMPANY · Merck & Co., Inc. · AbbVie Inc. · PFIZER INC · BRISTOL-MYERS SQUIBB COMPANY · ABBOTT LABORATORIES · Universe Pharmaceuticals INC · TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Stock screener

Watchlist